Article Details

EMA to quickly review Eli Lilly, Incyte arthritis drug for COVID-19 use

Retrieved on: 2021-04-29 15:45:00

Tags for this article:

Click the tags to see associated articles and topics

EMA to quickly review Eli Lilly, Incyte arthritis drug for COVID-19 use. View article details on hiswai:

Excerpt

While Actemra and Kevzara are large-molecule monoclonal antibodies, Olumiant is a so-called Janus kinase (JAK) inhibitor small-molecule drug that ...

Article found on: www.reuters.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up